Bilateral subconjunctival hemorrhage secondary to abciximab use: case report
São Paulo med. j
; São Paulo med. j;137(2): 209-211, Mar.-Apr. 2019. tab, graf
Article
in En
| LILACS
| ID: biblio-1014641
Responsible library:
BR1.1
ABSTRACT
ABSTRACT CONTEXT There are no reports on cases of subconjunctival hemorrhage due to use of glycoprotein IIb/IIIa inhibitors. In this report, we present the case of a patient with bilateral subconjunctival hemorrhage after receiving abciximab. CASE REPORT A 40-year-old male patient underwent coronary angiography after acute anterior myocardial infarction and a coronary stent was placed. Abciximab was added to the therapy because of stent thrombosis. Bilateral subconjunctival hemorrhage was observed after the administration of the abciximab treatment. We treated our patient by stopping abciximab and administering artificial tears. CONCLUSİON For the first time in the literature, we presented the case of a patient with bilateral subconjunctival hemorrhage after receiving abciximab, which was managed conservatively.
Key words
Full text:
1
Collection:
01-internacional
Database:
LILACS
Main subject:
Eye Hemorrhage
/
Abciximab
/
Anticoagulants
Limits:
Adult
/
Humans
/
Male
Language:
En
Journal:
Sao Paulo Med J
/
São Paulo med. j
/
São Paulo med. j. (Online)
/
São Paulo medical journal (Impresso)
Journal subject:
Cirurgia Geral
/
Cincia
/
Ginecologia
/
MEDICINA
/
Medicina Interna
/
Obstetr¡cia
/
Pediatria
/
Sa£de Mental
/
Sa£de P£blica
Year:
2019
Document type:
Article
Affiliation country:
Turkey
Country of publication:
Brazil